Results
|
2781.
|
c-Myc-miR-29c-REV3L signalling pathway drives the acquisition of temozolomide resistance in glioblastoma. [electronic resource] by
- Luo, Hui
- Chen, Zhengxin
- Wang, Shuai
- Zhang, Rui
- Qiu, Wenjin
- Zhao, Lin
- Peng, Chenghao
- Xu, Ran
- Chen, Wanghao
- Wang, Hong-Wei
- Chen, Yuanyuan
- Yang, Jingmin
- Zhang, Xiaotian
- Zhang, Shuyu
- Chen, Dan
- Wu, Wenting
- Zhao, Chunsheng
- Cheng, Gang
- Jiang, Tao
- Lu, Daru
- You, Yongping
- Liu, Ning
- Wang, Huibo
Producer: 20160504
In:
Brain : a journal of neurology vol. 138
Availability: No items available.
|
|
2782.
|
|
|
2783.
|
|
|
2784.
|
Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeutic. [electronic resource] by
- Volpin, F
- Casaos, J
- Sesen, J
- Mangraviti, A
- Choi, J
- Gorelick, N
- Frikeche, J
- Lott, T
- Felder, R
- Scotland, S J
- Eisinger-Mathason, T S K
- Brem, H
- Tyler, B
- Skuli, N
Producer: 20170922
In:
Oncogene vol. 36
Availability: No items available.
|
|
2785.
|
|
|
2786.
|
In vitro nuclear magnetic resonance spectroscopy metabolic biomarkers for the combination of temozolomide with PI3K inhibition in paediatric glioblastoma cells. [electronic resource] by
- Al-Saffar, Nada M S
- Agliano, Alice
- Marshall, Lynley V
- Jackson, L Elizabeth
- Balarajah, Geetha
- Sidhu, Jasmin
- Clarke, Paul A
- Jones, Chris
- Workman, Paul
- Pearson, Andrew D J
- Leach, Martin O
Producer: 20170921
In:
PloS one vol. 12
Availability: No items available.
|
|
2787.
|
Systemic Intravenous Adoptive Transfer of Autologous Lymphokine-activated αβ T-Cells Improves Temozolomide-induced Lymphopenia in Patients with Glioma. [electronic resource] by
- Kanemura, Yonehiro
- Sumida, Miho
- Okita, Yoshiko
- Yoshioka, Ema
- Yamamoto, Atsuyo
- Kanematsu, Daisuke
- Handa, Yukako
- Fukusumi, Hayato
- Inazawa, Yui
- Takada, A I
- Nonaka, Masahiro
- Nakajima, Shin
- Mori, Kanji
- Goto, Shigenori
- Kamigaki, Takashi
- Shofuda, Tomoko
- Moriuchi, Shusuke
- Yamasaki, Mami
Producer: 20170825
In:
Anticancer research vol. 37
Availability: No items available.
|
|
2788.
|
NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma. [electronic resource] by
- Gilbert, Mark R
- Pugh, Stephanie L
- Aldape, Ken
- Sorensen, A Gregory
- Mikkelsen, Tom
- Penas-Prado, Marta
- Bokstein, Felix
- Kwok, Young
- Lee, R Jeffrey
- Mehta, Minesh
Producer: 20171226
In:
Journal of neuro-oncology vol. 131
Availability: No items available.
|
|
2789.
|
|
|
2790.
|
|
|
2791.
|
|
|
2792.
|
Connexin 43 Inhibition Sensitizes Chemoresistant Glioblastoma Cells to Temozolomide. [electronic resource] by
- Murphy, Susan F
- Varghese, Robin T
- Lamouille, Samy
- Guo, Sujuan
- Pridham, Kevin J
- Kanabur, Pratik
- Osimani, Alyssa M
- Sharma, Shaan
- Jourdan, Jane
- Rodgers, Cara M
- Simonds, Gary R
- Gourdie, Robert G
- Sheng, Zhi
Producer: 20160606
In:
Cancer research vol. 76
Availability: No items available.
|
|
2793.
|
|
|
2794.
|
|
|
2795.
|
|
|
2796.
|
Interferon-β sensitizes human malignant melanoma cells to temozolomide-induced apoptosis and autophagy. [electronic resource] by
- Makita, Kotaro
- Hara, Hiroyuki
- Sano, Emiko
- Okamoto, Yutaka
- Ochiai, Yushi
- Harada, Tomonori
- Ueda, Takuya
- Nakayama, Tomohiro
- Aizawa, Shin
- Yoshino, Atsuo
Producer: 20190813
In:
International journal of oncology vol. 54
Availability: No items available.
|
|
2797.
|
|
|
2798.
|
|
|
2799.
|
|
|
2800.
|
|